Skip to main content

Table 3 The results of the budget impact analysis

From: Value of cannabidiol as adjunctive treatment for Lennox Gastaut syndrome: cost-effectiveness and budget impact analysis

Year

2024

2025

2026

2027

2028

Iran population

86369815

87406253

88455128

89516589

90590788

Population of LGS patients

16770

16971

17175

17380

17589

CBD market share

.1

0.2

.3

.4

.5

Scenario 1 (without CBD)

10125801

10247164

10369984

10494277

10620062

Scenario 2 (with CBD)

10349219

10699357

11056403

11420472

11791683

Budget impact

223419

452193

686419

926195

1171621